Clinical Trial Update: A Study of GLB-001 in Patients With Myeloid Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating GLB-001 in patients with myeloid malignancies is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Essential Thrombocythemia
• Myelodysplastic Syndromes
• Myelofibrosis
• Myeloid Malignancies
• Polycythemia Vera

Drugs mentioned

• GLB-001

Snippet

Sponsor: Hangzhou GluBio Pharmaceutical Co., Ltd. | Conditions: Polycythemia Vera, Essential Thrombocythemia | Phase 1 | Status: RECRUITING